Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Submitted by
admin
on June 13, 2016 - 10:36am
Source:
Forbes
News Tags:
Mitchell Gold
Dendreon
cancer immunotherapy
Alpine Immune Sciences
Headline:
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Do Not Allow Advertisers to Use My Personal information
